Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids, helping advance life science research and genetic medicine development.
Invitrogen’s Vivofectamine Delivery Solutions offer two tailored portfolios: the basic research portfolio with catalog LNP reagents for academic researchers, and the drug development portfolio with custom LNP reagents and services for drug developers. Together, both portfolios enable scientists globally to help reduce the time and cost of their advanced innovations.
Invitrogen Vivofectamine Delivery Solutions are intended for research use only.
